Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/9/2025

Oral Ivermectin Dosing for Head Lice

  • The American Academy of Pediatrics recommends administering 400 μg/kg of oral ivermectin as a single dose, repeated after 7 days, for patients weighing at least 15 kg 1, 2, 3
  • The 400 μg/kg regimen has demonstrated superior efficacy compared to the traditional 200 μg/kg regimen, with a cure rate of 95.2% in intention-to-treat analysis 1

Critical Safety Restrictions

  • The American Academy of Pediatrics advises against using oral ivermectin in children weighing less than 15 kg due to neurotoxicity concerns 1, 2, 3
  • Ivermectin can cross the blood-brain barrier and block essential neural transmission, with young children at higher risk 1

Clinical Context and Indications

  • The Centers for Disease Control and Prevention recommend reserving oral ivermectin for head lice resistant to all topical agents, including permethrin, malathion, spinosad, and benzyl alcohol 2, 3
  • Oral ivermectin should be considered when topical treatments have failed despite correct application 1

Important Caveats

  • The FDA has not approved oral ivermectin as a pediculicide, and its use represents off-label treatment, though supported by clinical evidence 1